Inventor · disambiguated record
Hanimi Reddy Bapatu
Also filed as: BAPATU HANIMI REDDY
8 granted patents·5 pending applications·19 citations·filing 2019–2025
80Inventor score
Top patents by PatentIndex Score
13 records- 0197US10874671B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Dec 29, 2020·17 cites·23 claims
- 0292US11793809B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Oct 24, 2023·2 cites·9 claims
- 0384US12403140B2Pharmaceutical compositions of nilotinibAZURITY PHARMACEUTICALS INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 0482US2025032508A1Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 0581US2025332165A1Pharmaceutical compositions of nilotinibAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0680US12138271B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·0 cites·16 claims
- 0775US11642355B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2022·Granted May 9, 2023·0 cites·15 claims
- 0872US2024122858A1Modified-release dosage forms of ruxolitinibSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 0971US11311554B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2019·Granted Apr 26, 2022·0 cites·6 claims
- 1068US2023172863A1Modified-release dosage forms of ruxolitinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 1167US11103502B2Pharmaceutical compositions of lurasidoneSLAYBACK PHARMA LLC·Filed 2019·Granted Aug 31, 2021·0 cites·7 claims
- 1259US11103503B2Pharmaceutical compositions of LurasidoneSLAYBACK PHARMA LLC·Filed 2020·Granted Aug 31, 2021·0 cites·12 claims
- 1348US2021121480A1Stable pharmaceutical compositions containing estradiol and progesterone for oral administrationSLAYBACK PHARMA LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hanimi Reddy Bapatu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →